Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Vaccines × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Uterine Cervical Neoplasms 2 Influenza, Human 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Sarcoma 1 Recurrence 1 Psoriasis 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Medullary cystic kidney disease 1 1 Lung Neoplasms 1 Glioblastoma 1 Epstein-Barr Virus Infections 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Crohn Disease 1 Condylomata Acuminata 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Temozolomide 140 Bevacizumab 80 Radiotherapy 69 Magnetic Resonance Spectroscopy 22 Radiation 18 Irinotecan 18 pembrolizumab 17 Lomustine 16 Carmustine 15 Surgical Procedures, Operative 13 Nivolumab 11 Erlotinib Hydrochloride 11 sargramostim 9 Thalidomide 9 Specimen Handling 9 Chemotherapy, Adjuvant 9 Aminolevulinic Acid 9 Carboplatin 8 Cilengitide 7 Sunitinib 6 Immunoglobulin G 6 Etoposide 6 Disulfides 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Radiotherapy, Intensity-Modulated 5 Radiosurgery 5 Metformin 5 Imatinib Mesylate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04523688 2025-07-22

Combi G-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡